PDF herunterladen
Klin Monbl Augenheilkd 2023; 240(09): 1060-1070
DOI: 10.1055/a-2108-6758
Übersicht

Volkskrankheit diabetische Retinopathie

Artikel in mehreren Sprachen: deutsch | English
Georg Spital
1   Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
,
Henrik Faatz
1   Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
2   Achim-Wessing-Institut für Ophthalmologische Bildgebung, Universität Essen, Deutschland
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Die diabetische Retinopathie (DR) ist eine der häufigsten Komplikationen von Diabetes mellitus und eine der häufigsten Ursachen einer Sehminderung im Erwerbsalter in der westlichen Welt. Die Behandlung der DR hängt von der Ausprägung ab, daher ist es von großer Bedeutung, die Patienten möglichst früh zu detektieren, um eine frühzeitige Behandlung einzuleiten und das Sehvermögen zu erhalten. Trotz derzeit unzureichender Screeningteilnahme frequentieren Menschen mit Diabetes bereits überdurchschnittlich häufig augenärztliche Praxen und Kliniken. Ihre Betreuung samt Diagnostik und Therapie nimmt seit Jahren einen wachsenden Anteil der augenärztlichen Tätigkeit ein. Da weltweit die Diabetesprävalenz dramatisch zunimmt und auch für Deutschland eine weitere Zunahme prognostiziert wird, dürfte die Herausforderung für die Augenärztinnen und Augenärzte noch erheblich wachsen. Gleichzeitig werden die diagnostischen Möglichkeiten zur Differenzierung einer DR und die therapeutischen Maßnahmen – gerade mit der IVOM-Therapie – immer aufwendiger, was die zeitliche Belastung im klinischen Alltag erhöht. Die Hoffnung, Versorgungsengpässe zu vermeiden und Screeningraten sowie die Visusprognose bei Patienten mit DR weiter zu verbessern, beruht u. a. auf einem kameraassistierten Screening, unterstützt durch künstliche Intelligenz. Auch eine bessere Diabetesbehandlung, um die Prävalenz der DR zu senken, sowie länger wirksamere Medikamente für die Behandlung einer DR könnten in der Zukunft die Versorgung der Betroffenen verbessern und helfen, augenärztliche Praxen zu entlasten.

Schlüsselwörter

diabetische Retinopathie - diabetisches Makulaödem - Vorsorgeuntersuchung - Diabetes mellitus


Publikationsverlauf

Eingereicht: 11. Mai 2023

Angenommen: 19. Mai 2023

Artikel online veröffentlicht:
04. September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Saeedi P, Petersohn I, Salpea P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843
    CrossrefPubMedSuche in Google Scholar
  • 2 Ogurtsova K, Guariguata L, Barengo NC. et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract 2022; 183: 109118
    CrossrefPubMedSuche in Google Scholar
  • 3 Diaz-Valencia PA, Bougnères P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 2015; 15: 255
    CrossrefPubMedSuche in Google Scholar
  • 4 Tuomi T, Groop LC, Zimmet PZ. et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-362
    CrossrefPubMedSuche in Google Scholar
  • 5 Ahlqvist E, Storm P, Käräjämäki A. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361-369
    CrossrefPubMedSuche in Google Scholar
  • 6 Ponto KA, Koenig J, Peto T. et al. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS). Diabetologia 2016; 59: 1913-1919
    CrossrefPubMedSuche in Google Scholar
  • 7 Schuster AK, Wolfram C, Pfeiffer N. et al. Augenheilkunde 2019 – Wo stehen wir?. Ophthalmologe 2019; 116: 829-837
    CrossrefPubMedSuche in Google Scholar
  • 8 Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 2568-2569
    CrossrefPubMedSuche in Google Scholar
  • 9 World Health Organization (WHO). TADDS: tool for the assessment of diabetic retinopathy and diabetes management systems. Im Internet (Stand: 17.04.2023): https://www.who.int/publications/i/item/tadds-tool-for-the-assessment-of-diabetic-retinopathy-and-diabetes-management-systems
    PubMed
  • 10 Hainsworth DP, Bebu I, Aiello LP. et al. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care 2019; 42: 875-882
    CrossrefPubMedSuche in Google Scholar
  • 11 Basina M, Maahs DM. Age at type 1 diabetes onset: a new risk factor and call for focused treatment. The Lancet 2018; 392: 453-454
    CrossrefPubMedSuche in Google Scholar
  • 12 Teo ZL, Tham YC, Yu M. et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 2021; 128: 1580-1591
    CrossrefPubMedSuche in Google Scholar
  • 13 Li JQ, Welchowski T, Schmid M. et al. Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis. Eur J Epidemiol 2020; 35: 11-23
    CrossrefPubMedSuche in Google Scholar
  • 14 Teo ZL, Tham YC, Yu M. et al. Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective. Eye (Lond) 2020; 34: 1255-1261
    CrossrefPubMedSuche in Google Scholar
  • 15 Hristova E, Koseva D, Zlatarova Z. et al. Diabetic Retinopathy Screening and Registration in Europe-Narrative Review. Healthcare (Basel) 2021; 9: 745
    CrossrefPubMedSuche in Google Scholar
  • 16 Schmidt C, Reitzle L, Dreß J. et al. [Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 93-102
    CrossrefPubMedSuche in Google Scholar
  • 17 Hesse L, Grüsser M, Hoffstadt K. et al. [Population-based study of diabetic retinopathy in Wolfsburg]. Ophthalmologe 2001; 98: 1065-1068
    CrossrefPubMedSuche in Google Scholar
  • 18 Hammes HP, Welp R, Kempe HP. et al. Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database. PLoS One 2015; 10: e0132492
    Suche in Google Scholar
  • 19 Hammes HP, Kerner W, Hofer S. et al. Diabetic retinopathy in type 1 diabetes – a contemporary analysis of 8,784 patients. Diabetologia 2011; 54: 1977-1984
    Suche in Google Scholar
  • 20 Groos S, Kretschmann J, Weber A. et al. Qualitätsbericht 2021: Disease-Management-Programme in Nordrhein. Im Internet (Stand: 17.07.2023): https://www.kgnw.de/service/dmp/dmp-nordrhein-qualitaetsbericht-2021
    PubMed
  • 21 Blum M, Kloos C, Müller N. et al. [Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002–2004]. Ophthalmologe 2007; 104: 499-500 502–504
    CrossrefPubMedSuche in Google Scholar
  • 22 Huppertz E, Pieper L, Klotsche J. et al. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled – results of the DETECT study. Exp Clin Endocrinol Diabetes 2009; 117: 6-14
    Thieme ConnectPubMedSuche in Google Scholar
  • 23 Heller T, Blum M, Spraul M. et al. [Diabetic co-morbidities: prevalences in Germany]. Dtsch Med Wochenschr 2014; 139: 786-791
    Thieme ConnectPubMedSuche in Google Scholar
  • 24 Goffrier B, Schulz M, Bätzing-Feigenbaum J. Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas-Bericht Nr. 17/03. 23.02.2017. Im Internet (Stand: 17.07.2023): https://www.versorgungsatlas.de/themen/alle-analysen-nach-datum-sortiert/?tab=6&uid=79
    CrossrefPubMed
  • 25 Wilke RGH, Finger RP, Sachs HG. [Real-life Data on the Treatment of Diabetic Macular Oedema in Germany]. Klin Monbl Augenheilkd 2017; 234: 1502-1507
    Thieme ConnectPubMedSuche in Google Scholar
  • 26 Stefanickova J, Cunha-Vaz J, Ulbig M. et al. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmol 2018; 96: e942-e949
    CrossrefPubMedSuche in Google Scholar
  • 27 Faatz H, Rothaus K, Westhues D. et al. [Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor (VEGF) treatment of diabetic macular edema in the clinical routine: Comparison between cooperative and unicentric organization of treatment]. Ophthalmologe 2020; 117: 557-565
    CrossrefPubMedSuche in Google Scholar
  • 28 Finger RP, Fimmers R, Holz FG. et al. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci 2011; 52: 4381-4389
    CrossrefPubMedSuche in Google Scholar
  • 29 Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med 2012; 366: 1227-1239
    CrossrefPubMedSuche in Google Scholar
  • 30 Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol 2021; 17: 195-206
    CrossrefPubMedSuche in Google Scholar
  • 31 Yau JWY, Rogers SL, Kawasaki R. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-564
    CrossrefPubMedSuche in Google Scholar
  • 32 Lachin JM, Genuth S, Nathan DM. et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial–revisited. Diabetes 2008; 57: 995-1001
    CrossrefPubMedSuche in Google Scholar
  • 33 Zhao M, Gelize E, Levy R. et al. Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy. Diabetes 2021; 70: 2668-2682
    CrossrefPubMedSuche in Google Scholar
  • 34 Reid LJ, Gibb FW, Colhoun H. et al. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. Diabetologia 2021; 64: 1725-1736
    CrossrefPubMedSuche in Google Scholar
  • 35 Zhang P, Kumar A, Katz LS. et al. Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell Proliferation. Diabetes 2015; 64: 4158-4170
    CrossrefPubMedSuche in Google Scholar
  • 36 Do DV, Han G, Abariga SA. et al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev 2023; (03) CD006127
    CrossrefPubMedSuche in Google Scholar
  • 37 Keech AC, Mitchell P, Summanen PA. et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370: 1687-1697
    CrossrefPubMedSuche in Google Scholar
  • 38 Meer E, Bavinger JC, Yu Y. et al. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmol 2022; 140: 529-532
    CrossrefPubMedSuche in Google Scholar
  • 39 Li Y, Su X, Ye Q. et al. The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies. Ren Fail 2021; 43: 231-240
    CrossrefPubMedSuche in Google Scholar
  • 40 Cosentino F, Grant PJ, Aboyans V. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41: 255-323
    CrossrefPubMedSuche in Google Scholar
  • 41 Ziemssen F, Lemmen K, Bertram B. et al. [National guidelines for treatment of diabetic retinopathy: Second edition of the national guidelines for treatment of diabetic retinopathy]. Ophthalmologe 2016; 113: 623-638
    CrossrefPubMedSuche in Google Scholar
  • 42 Wang J, Xin X, Luo W. et al. Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes. Invest Ophthalmol Vis Sci 2020; 61: 25
    CrossrefPubMedSuche in Google Scholar
  • 43 [Anonymous] Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98 (5 Suppl): 766-785
    PubMedSuche in Google Scholar
  • 44 Writing Committee for the Diabetic Retinopathy Clinical Research Network. Fong DS, Strauber SF, Aiello LP. et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007; 125: 469-480
    CrossrefPubMedSuche in Google Scholar
  • 45 [Anonymous] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806
    CrossrefPubMedSuche in Google Scholar
  • 46 Zhang X, Saaddine JB, Chou CF. et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304: 649-656
    CrossrefPubMedSuche in Google Scholar
  • 47 Claessen H, Kvitkina T, Narres M. et al. Markedly Decreasing Incidence of Blindness in People With and Without Diabetes in Southern Germany. Diabetes Care 2018; 41: 478-484
    CrossrefPubMedSuche in Google Scholar
  • 48 Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003–2016. Acta Diabetol 2017; 54: 515-525
    CrossrefPubMedSuche in Google Scholar
  • 49 Bertram B, Gante C, Hilgers RD. [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration: Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices]. Ophthalmologe 2014; 111: 757-764
    CrossrefPubMedSuche in Google Scholar
  • 50 Schuster AK, Wolfram C, Pfeiffer N. et al. [Ophthalmology 2019-where do we stand?: An analysis of the treatment situation in Germany]. Ophthalmologe 2019; 116: 829-837
    CrossrefPubMedSuche in Google Scholar
  • 51 Schuster AK, Wolfram C, Bertram B. et al. [Who visits an ophthalmologist and how often? Results of the German nationwide adult health survey (DEGS1)]. Ophthalmologe 2018; 115: 1042-1049
    CrossrefPubMedSuche in Google Scholar
  • 52 Kreft D, McGuinness MB, Doblhammer G. et al. Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 – A prospective cohort study based on health claims data. PLoS One 2018; 13: e0195426
    Suche in Google Scholar
  • 53 Baumeister SE, Schomerus G, Andersen RM. et al. Trends of barriers to eye care among adults with diagnosed diabetes in Germany, 1997–2012. Nutr Metab Cardiovasc Dis 2015; 25: 906-915
    CrossrefPubMedSuche in Google Scholar
  • 54 Wenzel M, Schayan K, Wirbelauer C. et al. Ambulante und stationäre Intraokularchirurgie 2020/21: Ergebnisse der aktuellen Umfrage im Corona-Jahr von BDOC, BVA, DGII und DOG. Im Internet (Stand: 17.07.2023): http://bdoc.info/dl/aktuelles_ambulante-intraokularchirurgie_wenzel-et-al-umfrage-2020.pdf
    PubMed
  • 55 Wenzel M, Kohnen T, Scharrer A. et al. Umfrage von DGII, BVA und BDOC zur ambulanten Intraokularchirurgie 2009. 2010. Im Internet (Stand: 17.07.2023): https://www.dgii.org/uploads/jahresband/2010/Wenzel.pdf
    PubMed
  • 56 König SF, Spital G, Ziemssen F. et al. [Photo-based examination for diabetic eye pathologies in a German ophthalmological practice without personal doctor-patient contact]. Ophthalmologie 2023; 120: 301-308
    CrossrefPubMedSuche in Google Scholar
  • 57 Paul S, Tayar A, Morawiec-Kisiel E. et al. [Use of artificial intelligence in screening for diabetic retinopathy at a tertiary diabetes center]. Ophthalmologie 2022; 119: 705-713
    CrossrefPubMedSuche in Google Scholar
  • 58 Stebbins K, Kieltyka S, Chaum E. Follow-Up Compliance for Patients Diagnosed with Diabetic Retinopathy After Teleretinal Imaging in Primary Care. Telemed J E Health 2021; 27: 303-307
    CrossrefPubMedSuche in Google Scholar
  • 59 Channa R, Wolf RM, Abràmoff MD. et al. Effectiveness of artificial intelligence screening in preventing vision loss from diabetes: a policy model. NPJ Digit Med 2023; 6: 53
    CrossrefPubMedSuche in Google Scholar
  • 60 Rajalakshmi R, Subashini R, Anjana RM. et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye (Lond) 2018; 32: 1138-1144
    CrossrefPubMedSuche in Google Scholar
  • 61 Kumari S, Venkatesh P, Tandon N. et al. Selfie fundus imaging for diabetic retinopathy screening. Eye (Lond) 2022; 36: 1988-1993
    CrossrefPubMedSuche in Google Scholar
  • 62 Ryu G, Lee K, Park D. et al. A deep learning model for identifying diabetic retinopathy using optical coherence tomography angiography. Sci Rep 2021; 11: 23024
    CrossrefPubMedSuche in Google Scholar
  • 63 Maturi RK, Glassman AR, Josic K. et al. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs. Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol 2021; 139: 701-712
    CrossrefPubMedSuche in Google Scholar